Having shown that the stroma-derived antigen vimentin is displayed on the surface of viable stromal cells, we asked whether this BCR-antigen interaction can protect CLL 014 cells from apoptosis. The gene discussed is VIM; the disease is B-cell chronic lymphocytic leukemia.